MIL-OSI USA: TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

Press/Media

Period	5 Jun 2018

Media coverage

Title	MIL-OSI USA: TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
Media name/outlet	Foreign Affairs.co.nz
Country/Territory	New Zealand
Date	5/06/18
URL	https://foreignaffairs.co.nz/2018/06/05/mil-osi-usa-tailorx-trial-finds-most-women-with-early-breast-cancer-do-not-benefit-from-chemotherapy/
Persons	Joseph Sparano